Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation
- PMID: 16219905
- DOI: 10.1124/mol.105.017400
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation
Abstract
Curcumin (diferuloylmethane), an anti-inflammatory agent used in traditional medicine, has been shown to suppress cellular transformation, proliferation, invasion, angiogenesis, and metastasis through a mechanism not fully understood. Because several genes that mediate these processes are regulated by nuclear factor-kappaB (NF-kappaB), we have postulated that curcumin mediates its activity by modulating NF-kappaB activation. Indeed, our laboratory has shown previously that curcumin can suppress NF-kappaB activation induced by a variety of agents (J Biol Chem 270:24995-50000, 1995). In the present study, we investigated the mechanism by which curcumin manifests its effect on NF-kappaB and NF-kappaB-regulated gene expression. Screening of 20 different analogs of curcumin showed that curcumin was the most potent analog in suppressing the tumor necrosis factor (TNF)-induced NF-kappaB activation. Curcumin inhibited TNF-induced NF-kappaB-dependent reporter gene expression in a dose-dependent manner. Curcumin also suppressed NF-kappaB reporter activity induced by tumor necrosis factor receptor (TNFR)1, TNFR2, NF-kappaB-inducing kinase, IkappaB kinase complex (IKK), and the p65 subunit of NF-kappaB. Such TNF-induced NF-kappaB-regulated gene products involved in cellular proliferation [cyclooxygenase-2 (COX-2), cyclin D1, and c-myc], antiapoptosis [inhibitor of apoptosis protein (IAP)1, IAP2, X-chromosome-linked IAP, Bcl-2, Bcl-x(L), Bfl-1/A1, TNF receptor-associated factor 1, and cellular Fas-associated death domain protein-like interleukin-1beta-converting enzyme inhibitory protein-like inhibitory protein], and metastasis (vascular endothelial growth factor, matrix metalloproteinase-9, and intercellular adhesion molecule-1) were also down-regulated by curcumin. COX-2 promoter activity induced by TNF was abrogated by curcumin. We found that curcumin suppressed TNF-induced nuclear translocation of p65, which corresponded with the sequential suppression of IkappaBalpha kinase activity, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 phosphorylation, p65 nuclear translocation, and p65 acetylation. Curcumin also inhibited TNF-induced Akt activation and its association with IKK. Glutathione and dithiothreitol reversed the effect of curcumin on TNF-induced NF-kappaB activation. Overall, our results indicated that curcumin inhibits NF-kappaB activation and NF-kappaB-regulated gene expression through inhibition of IKK and Akt activation.
Similar articles
-
Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.Oncogene. 2007 Feb 22;26(8):1201-12. doi: 10.1038/sj.onc.1209906. Epub 2006 Aug 21. Oncogene. 2007. PMID: 16924232
-
Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression.Oncogene. 2006 Mar 9;25(10):1463-73. doi: 10.1038/sj.onc.1209194. Oncogene. 2006. PMID: 16331273
-
Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion.Oncogene. 2005 Oct 20;24(46):6957-69. doi: 10.1038/sj.onc.1208845. Oncogene. 2005. PMID: 16007145
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.Trends Biochem Sci. 2005 Jan;30(1):43-52. doi: 10.1016/j.tibs.2004.11.009. Trends Biochem Sci. 2005. PMID: 15653325 Review.
Cited by
-
Discovery of curcumin, a component of golden spice, and its miraculous biological activities.Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283-99. doi: 10.1111/j.1440-1681.2011.05648.x. Clin Exp Pharmacol Physiol. 2012. PMID: 22118895 Free PMC article. Review.
-
Anthocyanins from Vitis coignetiae Pulliat Inhibit Cancer Invasion and Epithelial-Mesenchymal Transition, but These Effects Can Be Attenuated by Tumor Necrosis Factor in Human Uterine Cervical Cancer HeLa Cells.Evid Based Complement Alternat Med. 2013;2013:503043. doi: 10.1155/2013/503043. Epub 2013 Jun 20. Evid Based Complement Alternat Med. 2013. PMID: 23864892 Free PMC article.
-
Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells.Evid Based Complement Alternat Med. 2013;2013:745295. doi: 10.1155/2013/745295. Epub 2013 Mar 12. Evid Based Complement Alternat Med. 2013. PMID: 23573150 Free PMC article.
-
Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention.Cancer Res. 2010 Jun 1;70(11):4443-52. doi: 10.1158/0008-5472.CAN-09-4362. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460537 Free PMC article.
-
Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice.Carcinogenesis. 2009 Nov;30(11):1949-56. doi: 10.1093/carcin/bgp229. Epub 2009 Sep 30. Carcinogenesis. 2009. PMID: 19793800 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous